BRILITAS PHARMACEUTICALS EU OÜ
Date of report 07.02.2025
Open the reports you want to print
Employees and salaries
BRILITAS PHARMACEUTICALS EU OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
BRILITAS PHARMACEUTICALS EU OÜ
Decision-makers?
Relations: 1
Turnover:
Employees:
Quang Dăng Tran
★★☆☆
......
Credit Score: Trustworthy
Reputation score: 1060
Date of birth: ......
Active relations 1
*Every member of the management board may represent the private limited company in concluding all transactions.
BRILITAS PHARMACEUTICALS EU OÜ
History of right of representation?
Field
Professional Activities
Business age
2y
Beneficial country:
Viet Nam
Quang Dăng Tran ... - ...
2022
2023
2024
2025
2022
2023
2024
2025
BRILITAS PHARMACEUTICALS EU OÜ
Owners?
Former owners
BRILITAS PHARMACEUTICALS EU OÜ
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... |
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
BRILITAS PHARMACEUTICALS EU OÜ ...
GoodwillBRILITAS PHARMACEUTICALS EU OÜ
Taxes paid and estimated average salariesBRILITAS PHARMACEUTICALS EU OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
BRILITAS PHARMACEUTICALS EU OÜ ...
Sales revenue by countryBRILITAS PHARMACEUTICALS EU OÜ ...
Financial indicators and prognosisBRILITAS PHARMACEUTICALS EU OÜ ...
Financial raiting: "SATISFACTORY" (2024 prognosis)2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
BRILITAS PHARMACEUTICALS EU OÜ
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2023 | 01.01.2023–31.12.2023 | 17.05.2024 | ...... |
Liabilities and debts
BRILITAS PHARMACEUTICALS EU OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
BRILITAS PHARMACEUTICALS EU OÜ
Reports and assets-liabilities overview 07.02.2025?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
BRILITAS PHARMACEUTICALS EU OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
BRILITAS PHARMACEUTICALS EU OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | ...... € | ...... € | ...... € | ...... € | ...... |
BRILITAS PHARMACEUTICALS EU OÜ
Bailiff's enforcement proceedings as of 07.02.2025?
Bailiff's enforcement proceedings MISSING
BRILITAS PHARMACEUTICALS EU OÜ
Regulations of the Payment Order Department as of 07.02.2025?
Regulations of the Payment Order Department MISSING
BRILITAS PHARMACEUTICALS EU OÜ
Court orders in the register as of 07.02.2025?
Puuduste kõrvaldamise määrus
23.05.2024
Regulation number: Ä 50215655 / M1
Regulation status has entered into force: 19.05.2024
Date of enforcement of order or additional period: 23.05.2024
Regulation status: Puudused kõrvaldatud
BRILITAS PHARMACEUTICALS EU OÜ
Decisions of the Consumer Disputes Committee as of 07.02.2025?
Consumer disputes MISSING
BRILITAS PHARMACEUTICALS EU OÜ
Court hearings as of 07.02.2025?
Court hearings MISSING
BRILITAS PHARMACEUTICALS EU OÜ
Rulings as of 07.02.2025?
Court settlemets MISSING
BRILITAS PHARMACEUTICALS EU OÜ
Notices and announcements as of 07.02.2025?
Announcements MISSING
Marketing
Business network
BRILITAS PHARMACEUTICALS EU OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
BRILITAS PHARMACEUTICALS EU OÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.